Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, Roberts J, Flisser A, 1994. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 18 :879–885.
-
2
Kojic EM, White AC Jr, 2003. A positive enzyme-linked immunoelectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis 36 :7–9.
-
3
Mitchell GF, 1982. Genetic variation in resistance of mice of Taenia taeniaeformis: analysis of host-protective immunity and immune evasion. Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F, eds. Cysticercosis: Present State of Knowledge and Perspectives. New York: Academic Press, 575–584.
-
4
Williams JF, Engelkirk PG, Lindsay MC, 1982. Mechanisms of immunity in rodent cysticercosis. Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F, eds. Cysticercosis: Present State of Knowledge and Perspectives. New York: Academic Press, 621–632.
-
5
García HH, González AE, Gilman RH, Palacios LG, Jimenez I, Rodriguez S, Verastegui M, Wilkins P, Tsang VCW, 2001. Short report: transient antibody response in Taenia solium infection in field conditions - a major contributor to high sero-prevalence. Am J Trop Med Hyg 65 :31–32.
-
6
Del Brutto OH, Rajshekhar V, White AC, Tsang VCW, Nash TE, Takayanagui OM, Schantz PM, Evans CAW, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, García HH, 2001. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 :177–183.
-
7
García H, Evans CAW, Nash TE, Takayanagui OM, White AC, Botero D, Rajshekhar V, Tsang VCW, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez A, Gilman RH, Del Bruto O, 2002. Current consensus guidelines for treatment of neurocysticercosis. Clin Micro-biol Rev 15 :747–756.
-
8
Tsang VCW, Brand J, Boyer E, 1989. Enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis. J Infect Dis 159 :50–59.
-
9
Allan JC, Avila G, García-Noval J, Flisser A, Craig PS, 1990. Immunodiagnosis of taeniasis by coproantigen detection. Parasitology 101 :473–477.
-
10
Wilson MR, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VCW, 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectro-transfer blot in patients with neurocysticercosis. J Infect Dis 164 :1007–1009.
-
11
Proaño-Narváez JV, Meza-Lucas A, Mata-Ruiz O, García-Jerónimo RC, Correa D, 2002. Laboratory diagnosis of human neurocysticercosis: double blind comparison of ELISA and EITB. J Clin Microbiol 40 :2115–2118.
-
12
Bern C, Garcia HH, Evans C, González AE, Verastegui M, Tsang VCW, Gilman RH, 1999. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29 :1203–1209.
-
13
Theis JH, Goldsmith RS, Flisser A, Koss J, Chioino C, Plancarte A, Segura A, Widjana D, Sutisna P, 1994. Detection by immunoblot assay of antibodies to Taenia solium cysticerci in sera from residents of rural communities and from epileptic patients in Bali, Indonesia. Southeast Asian J Trop Med Public Health 25 :464–468.
-
14
García HH, Gilman RH, Catacora M, Verastegui M, González AE, Tsang VCW, 1997. Serologic evolution on neurocysticercosis patients after antiparasitic therapy. J Infect Dis 175 :486–489.
-
15
Ito A, Nakao M, Ito Y, Yuzawa I, Morishima H, Kawano N, Fijii K, 1999. Neurocysticercosis case with a single cyst in the brain showing dramatic drop in specific antibody titers within 1 year after curative surgical resection. Parasitol Int 48 :95–99.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 21 | 21 | 7 |
| Full Text Views | 357 | 70 | 0 |
| PDF Downloads | 34 | 14 | 0 |
SHORT REPORT: LIMITED AND SHORT-LASTING HUMORAL RESPONSE IN TAENIA SOLIUM: SEROPOSITIVE HOUSEHOLDS COMPARED WITH PATIENTS WITH NEUROCYSTICERCOSIS
ANTONIO MEZA-LUCAS
ANTONIO MEZA-LUCAS
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by ANTONIO MEZA-LUCAS in
Current site
Google Scholar
PubMed
Search for other papers by ANTONIO MEZA-LUCAS in
Current site
Google Scholar
PubMed
LAURA CARMONA-MIRANDA
LAURA CARMONA-MIRANDA
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by LAURA CARMONA-MIRANDA in
Current site
Google Scholar
PubMed
Search for other papers by LAURA CARMONA-MIRANDA in
Current site
Google Scholar
PubMed
ROBERTO C. GARCÍA-JERÓNIMO
ROBERTO C. GARCÍA-JERÓNIMO
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by ROBERTO C. GARCÍA-JERÓNIMO in
Current site
Google Scholar
PubMed
Search for other papers by ROBERTO C. GARCÍA-JERÓNIMO in
Current site
Google Scholar
PubMed
ALEJANDRA TORRERO-MIRANDA
ALEJANDRA TORRERO-MIRANDA
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by ALEJANDRA TORRERO-MIRANDA in
Current site
Google Scholar
PubMed
Search for other papers by ALEJANDRA TORRERO-MIRANDA in
Current site
Google Scholar
PubMed
GERMÁN GONZÁLEZ-HIDALGO
GERMÁN GONZÁLEZ-HIDALGO
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by GERMÁN GONZÁLEZ-HIDALGO in
Current site
Google Scholar
PubMed
Search for other papers by GERMÁN GONZÁLEZ-HIDALGO in
Current site
Google Scholar
PubMed
GUILLERMO LÓPEZ-CASTELLANOS
GUILLERMO LÓPEZ-CASTELLANOS
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by GUILLERMO LÓPEZ-CASTELLANOS in
Current site
Google Scholar
PubMed
Search for other papers by GUILLERMO LÓPEZ-CASTELLANOS in
Current site
Google Scholar
PubMed
DOLORES CORREA
DOLORES CORREA
Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Mexico City, Mexico; Hospital Regional de Zona No. 25, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico
Search for other papers by DOLORES CORREA in
Current site
Google Scholar
PubMed
Search for other papers by DOLORES CORREA in
Current site
Google Scholar
PubMed
Epidemiologic data suggest that 30–40% of Taenia solium-seropositive people become spontaneously negative without acquiring cysticercosis. To compare the responses of these individuals with those of patients with neurocysticercosis, we screened seropositive persons among family members of 16 patients. We searched for specific antibodies in patients and their 118 households by an enzyme-linked immunoelectrotransfer blot assay using specific glycoproteins of T. solium metacestodes. We found six seropositive individuals without neurocysticercosis among members of four families. The matching patients were young, harbored viable cysts, and had short evolution of disease. The baseline response of healthy seropositive individuals was scarce and showed a low frequency of antibodies against glycoproteins GP39-42 and GP24, which are immunodominant in patients with neurocysticercosis. Moreover, they became spontaneously negative in few months. The response of patients was heterogeneous as shown in other studies. The results of this work support a highly dynamic host-parasite immunologic interaction and suggest individual susceptibility or level of exposure among family members.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, Roberts J, Flisser A, 1994. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis 18 :879–885.
-
2
Kojic EM, White AC Jr, 2003. A positive enzyme-linked immunoelectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis 36 :7–9.
-
3
Mitchell GF, 1982. Genetic variation in resistance of mice of Taenia taeniaeformis: analysis of host-protective immunity and immune evasion. Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F, eds. Cysticercosis: Present State of Knowledge and Perspectives. New York: Academic Press, 575–584.
-
4
Williams JF, Engelkirk PG, Lindsay MC, 1982. Mechanisms of immunity in rodent cysticercosis. Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltrán F, eds. Cysticercosis: Present State of Knowledge and Perspectives. New York: Academic Press, 621–632.
-
5
García HH, González AE, Gilman RH, Palacios LG, Jimenez I, Rodriguez S, Verastegui M, Wilkins P, Tsang VCW, 2001. Short report: transient antibody response in Taenia solium infection in field conditions - a major contributor to high sero-prevalence. Am J Trop Med Hyg 65 :31–32.
-
6
Del Brutto OH, Rajshekhar V, White AC, Tsang VCW, Nash TE, Takayanagui OM, Schantz PM, Evans CAW, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, García HH, 2001. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 :177–183.
-
7
García H, Evans CAW, Nash TE, Takayanagui OM, White AC, Botero D, Rajshekhar V, Tsang VCW, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez A, Gilman RH, Del Bruto O, 2002. Current consensus guidelines for treatment of neurocysticercosis. Clin Micro-biol Rev 15 :747–756.
-
8
Tsang VCW, Brand J, Boyer E, 1989. Enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis. J Infect Dis 159 :50–59.
-
9
Allan JC, Avila G, García-Noval J, Flisser A, Craig PS, 1990. Immunodiagnosis of taeniasis by coproantigen detection. Parasitology 101 :473–477.
-
10
Wilson MR, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VCW, 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectro-transfer blot in patients with neurocysticercosis. J Infect Dis 164 :1007–1009.
-
11
Proaño-Narváez JV, Meza-Lucas A, Mata-Ruiz O, García-Jerónimo RC, Correa D, 2002. Laboratory diagnosis of human neurocysticercosis: double blind comparison of ELISA and EITB. J Clin Microbiol 40 :2115–2118.
-
12
Bern C, Garcia HH, Evans C, González AE, Verastegui M, Tsang VCW, Gilman RH, 1999. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29 :1203–1209.
-
13
Theis JH, Goldsmith RS, Flisser A, Koss J, Chioino C, Plancarte A, Segura A, Widjana D, Sutisna P, 1994. Detection by immunoblot assay of antibodies to Taenia solium cysticerci in sera from residents of rural communities and from epileptic patients in Bali, Indonesia. Southeast Asian J Trop Med Public Health 25 :464–468.
-
14
García HH, Gilman RH, Catacora M, Verastegui M, González AE, Tsang VCW, 1997. Serologic evolution on neurocysticercosis patients after antiparasitic therapy. J Infect Dis 175 :486–489.
-
15
Ito A, Nakao M, Ito Y, Yuzawa I, Morishima H, Kawano N, Fijii K, 1999. Neurocysticercosis case with a single cyst in the brain showing dramatic drop in specific antibody titers within 1 year after curative surgical resection. Parasitol Int 48 :95–99.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 21 | 21 | 7 |
| Full Text Views | 357 | 70 | 0 |
| PDF Downloads | 34 | 14 | 0 |